| Primary |
| Product Used For Unknown Indication |
57.2% |
| Alpha-1 Anti-trypsin Deficiency |
18.5% |
| Drug Use For Unknown Indication |
12.3% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Migraine |
1.0% |
| Asthma |
0.9% |
| Cough |
0.9% |
| Pain |
0.9% |
| Bronchitis Chronic |
0.8% |
| Hypothyroidism |
0.8% |
| Multiple Sclerosis |
0.8% |
| Diabetes Mellitus |
0.6% |
| Dyspnoea |
0.6% |
| Liver Disorder |
0.5% |
| Lung Transplant |
0.5% |
| Premedication |
0.5% |
| Anxiety |
0.4% |
| Depression |
0.4% |
| Dermatomyositis |
0.4% |
| Hypersensitivity |
0.4% |
|
| Death |
41.5% |
| Pneumonia |
18.1% |
| Respiratory Failure |
4.8% |
| Weight Decreased |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Pyrexia |
3.2% |
| Wheezing |
2.7% |
| Malaise |
2.1% |
| Multiple Sclerosis Relapse |
2.1% |
| Sinusitis |
2.1% |
| Weight Increased |
2.1% |
| Dyspnoea |
1.6% |
| Hepatic Failure |
1.6% |
| Lung Disorder |
1.6% |
| Myocardial Infarction |
1.6% |
| Pneumothorax |
1.6% |
| Pulmonary Mass |
1.6% |
| Pulmonary Oedema |
1.6% |
| Rash |
1.6% |
| Sepsis |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
33.2% |
| Alpha-1 Anti-trypsin Deficiency |
23.5% |
| Drug Use For Unknown Indication |
19.4% |
| Migraine |
6.0% |
| Cough |
4.1% |
| Multiple Sclerosis |
4.1% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Pain |
1.8% |
| Hypothyroidism |
1.4% |
| Asthma |
0.9% |
| Antitussive Therapy |
0.5% |
| Anxiety |
0.5% |
| Atrial Fibrillation |
0.5% |
| Depression |
0.5% |
| Drug Therapy Enhancement |
0.5% |
| Pulmonary Hypertension |
0.5% |
|
| Multiple Sclerosis Relapse |
10.3% |
| Pyrexia |
10.3% |
| Dizziness |
7.7% |
| Epistaxis |
7.7% |
| Fatigue |
7.7% |
| Influenza Like Illness |
7.7% |
| Herpes Zoster |
5.1% |
| Malaise |
5.1% |
| Respiratory Failure |
5.1% |
| Rotator Cuff Syndrome |
5.1% |
| Wheezing |
5.1% |
| Death |
2.6% |
| Erythema |
2.6% |
| Intestinal Perforation |
2.6% |
| Lung Transplant Rejection |
2.6% |
| Obliterative Bronchiolitis |
2.6% |
| Oxygen Saturation Decreased |
2.6% |
| Paralysis |
2.6% |
| Pneumonia |
2.6% |
| Pneumothorax |
2.6% |
|
| Concomitant |
| Alpha-1 Anti-trypsin Deficiency |
100.0% |
|
| White Blood Cell Count Decreased |
100.0% |
|
